kio-301
·Code: B-203
kio-301: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (2)
| Company | Phase |
|---|---|
| Kiora Pharmaceuticals Inc. (KPRX) | Phase 2 |
| Kiora Pharmaceuticals Inc. (KPRX) | Phase 2 |
Clinical Trials (1)
A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)
Frequently asked questions
Who is developing kio-301?
kio-301 is being developed by Kiora Pharmaceuticals Inc..
How many clinical trials involve kio-301?
BioSniper tracks 1 clinical trial involving kio-301.
Get deeper analysis on kio-301
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis